New 52 Week High Today

Vivos Inc RDGL:OTCQB

*Data is delayed | Exchange | USD
Last | 04/24/24 EDT
0.1187quote price arrow up+0.0137 (+13.0952%)
Volume
1,558,667
52 week range
0.04 - 0.12
Loading...
  • Open0.104
  • Day High0.12
  • Day Low0.1034
  • Prev Close0.1187
  • 52 Week High0.12
  • 52 Week High Date04/24/24
  • 52 Week Low0.04
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap46.062M
  • Shares Out387.89M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change64.25

KEY STATS

  • Open0.104
  • Day High0.12
  • Day Low0.1034
  • Prev Close0.1187
  • 52 Week High0.12
  • 52 Week High Date04/24/24
  • 52 Week Low0.04
  • 52 Week Low Date11/10/23
  • Market Cap46.062M
  • Shares Out387.89M
  • 10 Day Average Volume1.65M
  • Dividend-
  • Dividend Yield-
  • Beta1.33
  • YTD % Change64.25

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-16.43
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.793M
  • ROE (TTM)-191.65%
  • Revenue (TTM)19,500.00
  • Gross Margin (TTM)-30.97%
  • Net Margin (TTM)-14,844.92%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vivos Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vivos Inc. is a radiation oncology medical device company. The Company is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. The Company’s IsoPet division is focused on bringing RadioGel...
Carlton Cadwell
Chairman of the Board, Secretary
Michael Korenko Ph.D.
President, Chief Executive Officer, Director
Michael Pollack CPA
Interim Chief Financial Officer
Address
719 Jadwin Ave
Richland, WA
99352-4217
United States